Upgrading 18F-NaF radiopharmaceutical synthesis to scale production

  • That Nguyen Khac 108 Military Central Hospital
  • Dien Tran Van 108 Military Central Hospital
  • Rin Bui Thanh 108 Military Central Hospital
  • Dinh Nguyen Van 108 Military Central Hospital
  • Linh Pham Tuan 108 Military Central Hospital
  • Linh Nguyen Tran 108 Military Central Hospital

Main Article Content

Keywords

18F-NaF, important synthesis factors, 1000 ± 100mCi/batch

Abstract

Objective: To modulate a stable 18F-NaF at a production of 1000 ± 100mCi/batch. Subject and method: 18F-NaF, using a synthetic chemical process 18F-NaF at laboratory scale not exceeding 100mCi/batch. Synthesis formula: 1000 ± 100mCi 18F-NaF/15ml, NaCl 0.9%: 15ml; bombardment energy: 18MeV; Beam intensity 35 - 36.5µA, 30 minutes of bombardment; radioactive chemistry: NaCl 0.9%: 3ml; Water: 5ml; Synthesis time 15 minutes; adding 12ml of 0.9% NaCl to the final product vial. Investigating the appropriate bombardment time to produce 18F-NaF of 1000 ± 100mCi/batch and verifying critical process parameters for this procedure. Result: The radioactivity of 18F-NaF produced linear with a target shooting time of 15 to 30 minutes and with 30 minutes bombardment, it was possible to generate enough 1000 ± 100mCi of 18F-NaF to meet the goal of the study. Investigation of the critical parameters and the yield of 18F-NaF obtained showed that the 1000 ± 100mCi synthesis process was stable. Products of 3 consecutive batches met the main criteria according to the USP. Conclusion: Using the synthesis formula and specifications for the preparation of laboratory 18F-NaF not exceeding 100mCi/batch on a 30MeV cyclotron at 108 Military Central Hospital and 30 minutes of bombardment can produce 1000 ± 100mCi of 18F-NaF.

Article Details

References

1. Blau M, Ganatra R, Bender MA (1972) 18F-fluoride for bone imaging. Semin Nucl Med 2: 31-37.
2. Davis MA, Jones AG (1976) Comparison of 99mTc-labeled phosphate and phosphonate agents for skeletal imaging. Semin Nucl Med 6: 19-31.
3. Hawkins RA, Choi Y, Huang SC et al (1992) Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET. J Nucl Med 33: 633-642.
4. Hoh CK, Hawkins RA, Dahlbom M et al (1993) Whole body skeletal imaging with [18F] fluoride ion and PET. J Comput Assist Tomogr 17: 34-41.
5. Marina Bicalho Silveira, Marcella Araugio Soares et al (2010) Synthesis, quality control and dosimetry of the radiopharmaceutical 18F-sodium fluoride produced at the Center for Development of Nuclear Technology - CDTN. Brazilian Journal of Pharmaceutical Sciences 46(3): 563-569.
6. Gameiro C et al (2012) Routine production in a GMP environment of multiple 18F-radiopharmaceuticals on a disposable-based fully automated platform. ESRR 2012 April 26th-29th Nantes/France POSTER NUMBER:PP20. http://www.iba-worldwide.com
7. Rajeev Kumar et al (2014) Production of the PET bone agent 18F-fluoride ion, simultaneously with 18F-FDG by a single run of the medical cyclotron with minimal radiation exposure-a novel technique. Hell J Nucl Med 17(2): 106-110.
8. Tran Manh Thang et al (2019) Preparation of 18F-NaF radiopharmaceuticals using home-made automatic synthesis module at Hanoi Iradiation Center. Nuclear science and technology 9(1): 41-51.
9. Ferguson D et al (2011) Measurement of long lived radioactive impurities retained in the disposable cassettes onthe Tracerlab MX system during the production of [18F]FDG. Appl. Radiat. Isotopes doi:10.1016/j.apradiso.2011.05.028
10. Nandy SK, Rajan MGR and Soni PS (2007) Production of sterile [F-18]NaF for skeletal PET imaging. BARG 281: 16-23.